This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Complications following infusion, transfusion and therapeutic injection
ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
539 |
4. Check minimum number of eventsNone |
539 |
5. Include endpointsNone |
539 |
6. Filter based on genotype QC (FinnGen only) |
539 |
Control definitions (FinnGen only)
- Control exclude
- ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T8
- Name in latin
- Complicationes infusionis, transfusionis sive injectionis therapeuticae
Similar endpoints
↥List of similar endpoints to
Complications following infusion, transfusion and therapeutic injection
based on the number of shared cases.
Similar with more cases:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 539 | 319 | 220 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.10 |
| Median age at first event (years) | 58.77 | 55.68 | 63.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 492
- Matched controls
- 4920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
+∞
184.3
165
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
129.9
98.4
103
10
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
+∞
94.9
88
*
T80.1
ICD-10 Finland
Vascular complications following infusion, transfusion and therapeutic injection
+∞
86.0
80
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
46.1
77.0
94
25
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
+∞
72.7
68
*
T80.9
ICD-10 Finland
Unspecified complication following infusion, transfusion and therapeutic injection
+∞
64.0
60
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
302.9
54.3
54
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
26.6
44.0
61
26
H02AB02
ATC
dexamethasone; systemic
6.4
43.7
128
257
B01AB05
ATC
enoxaparin; parenteral
4.0
42.5
228
867
A04AA02
ATC
granisetron; systemic, transdermal
9.6
42.5
91
113
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
39.0
178
574
ZXD05
NOMESCO Finland
Urgent procedure
3.6
37.0
228
945
X59
ICD-10 Finland
Exposure to unspecified factor
4.5
35.4
147
427
T80.0
ICD-10 Finland
Air embolism following infusion, transfusion and therapeutic injection
+∞
34.8
33
*
JN4AD
NOMESCO Finland
Body CT examination
7.4
34.4
87
139
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
34.4
140
397
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
33.3
277
1403
N02AA05
ATC
oxycodone; systemic
4.4
30.3
124
349
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
113.8
30.0
32
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.6
29.6
56
54
B01AB10
ATC
tinzaparin; parenteral
6.6
29.5
80
140
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
+∞
28.4
27
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
28.2
162
607
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
79.8
27.1
30
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
27.0
218
1035
R50.9
ICD-10 Finland
Fever, unspecified
4.2
26.8
115
335
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
26.4
101
263
T80.4
ICD-10 Finland
Rh incompatibility reaction
+∞
26.3
25
*
JN4BD
NOMESCO Finland
Extensive body CT
4.7
26.2
97
244
N02AX02
ATC
tramadol; systemic, rectal
2.8
25.4
257
1391
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
24.4
92
235
T81.9
ICD-10 Finland
Unspecified complication of procedure
+∞
24.2
23
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.3
23.8
54
72
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
23.7
66
119
C03CA01
ATC
furosemide; systemic
2.9
23.2
178
799
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
240.7
22.8
23
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
22.0
21
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.2
22.0
90
248
T80.6
ICD-10 Finland
Other serum reactions
229.7
21.8
22
*
N02BE01
ATC
paracetamol; systemic, rectal
3.7
21.7
443
3501
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.4
21.6
45
52
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
21.5
221
1167
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.1
21.5
54
84
ZXE20
NOMESCO Finland
More than three and less than five hours
3.7
21.3
101
317
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
6.7
21.0
55
91
WZC30
NOMESCO Finland
Teaching
3.7
21.0
102
326
ZX120
NOMESCO Finland
Intravenous
4.4
20.8
81
212
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
218.8
20.7
21
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
20.4
100
321
T80.3
ICD-10 Finland
ABO incompatibility reaction
+∞
19.9
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
19.6
55
100
WW500
NOMESCO Finland
Blood transfusion
6.7
19.5
51
84
A02BC02
ATC
pantoprazole; systemic
2.4
19.0
342
2373
J01FF01
ATC
clindamycin; systemic
2.7
19.0
167
797
X58
ICD-10 Finland
Exposure to other specified factors
3.6
19.0
94
304
L03AA13
ATC
pegfilgrastim; parenteral
7.2
18.8
46
69
L01BC06
ATC
capecitabine; oral
7.9
18.7
43
59
J01MA12
ATC
levofloxacin; systemic
2.9
17.9
125
516
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
186.4
17.6
18
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
17.5
65
162
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
65.7
16.8
19
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
175.7
16.6
17
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
16.6
83
269
ZXE00
NOMESCO Finland
One hour or less
2.3
16.5
224
1314
A46
ICD-10 Finland
Erysipelas
3.2
16.5
95
341
L03AA14
ATC
lipegfilgrastim; parenteral
10.9
16.4
31
30
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.2
16.2
29
25
ZX070
NOMESCO Finland
Intensity modified radiotherapy
12.2
16.2
29
25
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.3
15.7
29
27
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.4
15.7
26
19
J01MA02
ATC
ciprofloxacin; systemic
2.2
15.3
208
1211
Z51.5
ICD-10 Finland
Palliative care
4.7
15.0
52
121
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
14.9
75
243
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.0
14.7
33
44
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
14.7
14
*
UJF32
NOMESCO Finland
Coloscopy
2.4
14.6
152
772
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
14.5
162
853
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
14.4
167
894
ZXA00
NOMESCO Finland
Right side
2.3
14.1
153
794
TQW11
NOMESCO Finland
Vacuum treatment of wound
13.2
14.0
24
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
13.9
94
375
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
13.9
42
84
AA1AD
NOMESCO Finland
CT of head and brain
2.4
13.8
136
671
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
13.7
62
185
J01DB01
ATC
cefalexin; oral
2.4
13.5
408
3294
130
Kela drug reimbursment
Malignant tumour
3.6
13.5
62
187
A04AA55
ATC
palonosetron, combinations; systemic
6.6
13.3
34
55
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.1
13.3
36
63
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.0
13.1
29
38
ZZA00
NOMESCO Finland
Split skin graft
8.0
13.1
29
38
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
29.3
13.0
17
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
13.0
79
294
R06.0
ICD-10 Finland
Dyspnoea
2.3
13.0
138
703
128
Kela drug reimbursment
Cancers of female genital organs
10.9
12.9
24
23
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
12.9
38
74
H02AB06
ATC
prednisolone; systemic
2.0
12.8
244
1604
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
12.8
68
230
R4110
NOMESCO Finland
Physiotherapy
2.3
12.7
143
750
Z3231
NOMESCO Finland
Registered nurse
2.2
12.7
153
827
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
12.7
50
132
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
71.7
12.6
14
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
12.5
82
319
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
12.5
193
1162
WX402
NOMESCO Finland
General anaesthesia
2.6
12.0
98
434
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
12.0
227
1473
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
12.0
59
188
C07AB07
ATC
bisoprolol; oral
2.0
11.9
239
1585
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
11.9
80
316
B01AA03
ATC
warfarin; systemic
2.4
11.9
111
527
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.0
11.8
26
34
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.9
11.7
38
83
S18
ICPC
Laceration/cut
2.0
11.6
211
1346
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
11.6
146
799
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.3
11.5
30
50
A41.9
ICD-10 Finland
Sepsis, unspecified
6.3
11.5
30
50
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.0
11.5
46
123
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
11.4
36
76
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.9
11.4
21
20
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
11.3
39
91
A11CC03
ATC
alfacalcidol; systemic
6.7
11.3
28
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
11.1
119
602
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.5
11.1
32
61
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
11.1
130
688
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
10.9
101
476
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.6
10.8
49
147
WX110
NOMESCO Finland
Local anesthesy
1.9
10.8
337
2599
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
10.7
60
209
UKC02
NOMESCO Finland
Cystoscopy
2.5
10.7
90
404
WX002
NOMESCO Finland
Sedation and analgesia
2.3
10.7
108
531
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
10.6
92
419
HA1AA
NOMESCO Finland
X-ray mammography
3.4
10.6
51
160
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.8
10.6
35
78
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
10.5
54
178
SPAT1255
SPAT
Intravenous administration of medicine
3.6
10.5
47
139
X57
ICD-10 Finland
Unspecified privation
8.0
10.5
23
30
A04AA01
ATC
ondansetron; systemic, rectal
3.5
10.5
50
156
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
+∞
10.4
10
*
XW000
NOMESCO Finland
Bone marrow biopsy
4.4
10.4
37
89
N03AX16
ATC
pregabalin; oral
2.1
10.4
129
698
R11
ICD-10 Finland
Nausea and vomiting
3.3
10.3
53
175
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.2
10.2
24
35
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.7
10.2
25
39
A04AD12
ATC
aprepitant; systemic
7.0
10.0
24
36
TK800
NOMESCO Finland
Hemodialysis
7.0
10.0
24
36
J01DA01
ATC
[U] cefalexin; systemic
1.8
9.7
303
2290
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
9.7
168
1033
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
5.2
9.7
29
58
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.4
9.7
34
81
N03AX12
ATC
gabapentin; oral
2.4
9.6
86
398
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
9.6
180
1138
V03AE01
ATC
polystyrene sulfonate; oral
9.4
9.6
19
21
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
10.3
9.6
18
18
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
9.5
120
650
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
9.5
38
103
Y88.0
ICD-10 Finland
Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
101.9
9.4
10
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
9.4
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
9.4
93
451
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
9.3
95
465
N05CF01
ATC
zopiclone; oral
1.9
9.3
164
1014
Z2446
NOMESCO Finland
Social worker
3.2
9.3
48
159
E86
ICD-10 Finland
Volume depletion
5.9
9.3
25
44
E0000UV
ATC
NA
1.9
9.3
197
1301
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
9.1
149
895
N18.0
ICD-10 Finland
End-stage renal disease
11.8
9.1
16
14
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.8
9.1
29
63
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
9.1
46
151
115
Kela drug reimbursment
Breast cancer
3.1
9.0
51
179
K56.7
ICD-10 Finland
Ileus, unspecified
7.7
9.0
20
27
L01CA04
ATC
vinorelbine; systemic
19.0
9.0
13
7
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
19.0
9.0
13
7
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
8.9
35
93
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
12.8
8.9
15
12
A41.8
ICD-10 Finland
Other specified sepsis
7.4
8.8
20
28
SPAT1263
SPAT
Sampling
1.8
8.8
217
1499
JAH00
NOMESCO Finland
Laparotomy
5.3
8.6
25
49
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
28.1
8.5
11
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
91.6
8.4
9
*
M79.6
ICD-10 Finland
Pain in limb
1.8
8.4
174
1130
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.4
8.4
21
34
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
8.4
93
473
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
8.4
28
64
WX892
NOMESCO Finland
Monitored bed care
2.9
8.4
50
184
R60.0
ICD-10 Finland
Localized oedema
2.6
8.4
63
266
T80.5
ICD-10 Finland
Anaphylactic shock due to serum
+∞
8.4
8
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
8.3
35
99
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
8.3
51
188
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.3
97
508
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
8.2
39
122
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.7
8.2
18
24
N06AX11
ATC
mirtazapine; oral
1.9
8.2
157
992
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
8.2
67
294
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.9
8.2
48
174
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
4.4
8.1
28
66
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.4
8.1
28
66
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
8.1
185
1236
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.4
8.0
18
25
L17
ICPC
Foot/toe symptom/complaint
1.9
8.0
125
734
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.7
8.0
26
58
B01AC04
ATC
clopidogrel; oral
2.2
8.0
82
403
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.8
8.0
19
29
JFB00
NOMESCO Finland
Partial resection of small intestine
8.0
7.9
17
22
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
7.9
49
182
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.3
7.9
13
10
A12AA04
ATC
calcium carbonate; oral
7.1
7.8
18
26
R52.9
ICD-10 Finland
Pain, unspecified
2.9
7.8
48
178
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
45.7
7.7
9
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
45.7
7.7
9
*
G56.4
ICD-10 Finland
Causalgia
45.7
7.7
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.6
7.7
17
23
N05BA01
ATC
diazepam; systemic, rectal
2.3
7.7
72
340
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.8
7.7
48
180
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.1
7.7
43
149
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
7.7
85
434
S97
ICPC
Chronic ulcer skin
3.4
7.6
35
107
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
12.1
7.6
13
11
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.1
7.6
13
11
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
12.1
7.6
13
11
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.6
7.6
21
39
H02AB09
ATC
hydrocortisone; systemic
5.6
7.6
21
39
L04AX01
ATC
azathioprine; systemic
4.3
7.6
27
66
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
7.6
137
844
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
10.3
7.6
14
14
L03AA02
ATC
filgrastim; parenteral
5.0
7.5
23
48
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
5.2
7.5
22
44
R18
ICD-10 Finland
Ascites
6.6
7.5
18
28
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
7.5
42
147
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.5
89
468
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
7.4
36
115
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
81.3
7.4
8
*
J01XX08
ATC
linezolid; systemic
81.3
7.4
8
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.1
7.3
38
128
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
+∞
7.3
7
*
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.1
7.3
27
69
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
16.0
7.3
11
7
TPX15
NOMESCO Finland
Removal of vascular injection port
16.0
7.3
11
7
ZXA05
NOMESCO Finland
Left side
1.9
7.2
125
756
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
7.2
68
321
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.1
7.1
15
19
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
7.1
242
1803
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.2
7.1
18
30
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.1
50
204
A06AH03
ATC
naloxegol; oral
12.3
7.1
12
10
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.0
7.1
14
16
A07AA09
ATC
vancomycin; oral
9.0
7.1
14
16
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
7.1
108
626
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
10.2
7.1
13
13
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.2
7.1
13
13
WW200
NOMESCO Finland
Immunization
4.4
7.0
24
57
M04AA01
ATC
allopurinol; systemic
2.3
7.0
67
319
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.7
7.0
22
48
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
7.0
41
150
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
14.0
6.9
11
8
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.7
6.9
28
78
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.9
186
1293
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
6.9
64
302
A02BC01
ATC
omeprazole; systemic
1.8
6.9
137
868
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
9.5
6.8
13
14
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.8
6.8
18
32
N05BA04
ATC
oxazepam; oral
1.8
6.8
122
749
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
17.0
6.8
10
6
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
6.8
32
101
N06AX21
ATC
duloxetine; oral
2.4
6.7
56
250
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.7
102
589
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.3
6.7
19
37
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.9
6.7
26
70
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.6
6.7
18
33
D07AA02
ATC
hydrocortisone; topical
2.1
6.7
72
364
SPAT1262
SPAT
Handing over of treatment supplies
2.0
6.7
91
506
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
6.6
73
369
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
10.2
6.6
12
12
SPAT1301
SPAT
No procedures
1.7
6.6
157
1051
J01CA04
ATC
amoxicillin; systemic
1.7
6.5
383
3286
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.3
6.5
16
26
A02BC05
ATC
esomeprazole; systemic
1.7
6.5
194
1386
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
6.5
100
580
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
70.7
6.4
7
*
I50.0
ICD-10 Finland
Congestive heart failure
2.8
6.4
41
157
R51.80
ICD-10 Finland
Headache
2.1
6.4
68
342
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.1
6.4
23
58
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
8.3
6.4
13
16
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
6.1
6.3
16
27
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
6.3
34
118
JFF10
NOMESCO Finland
Loop enterostomy
11.2
6.3
11
10
J01MA14
ATC
moxifloxacin; systemic
2.5
6.3
48
205
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
6.3
48
205
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
6.3
25
69
T84.1
ICD-10 Finland
Mechanical complication of internal fixation device of bones of limb
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
NFU00
NOMESCO Finland
Removal of partial prosthesis from hip joint, other or unspecified
+∞
6.3
6
*
T88.8
ICD-10 Finland
Other specified complications of surgical and medical care, not elsewhere classified
+∞
6.3
6
*
A28
ICPC
Limited function/disability NOS
2.1
6.3
71
366
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.2
6.3
14
20
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.1
6.2
18
36
J05AB11
ATC
valaciclovir; oral
2.2
6.2
66
329
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.2
6.2
30
97
ZX080
NOMESCO Finland
Image guided radiotherapy
4.8
6.2
19
41
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
6.1
72
375
J01AA02
ATC
doxycycline; systemic
1.7
6.1
359
3040
JKA20
NOMESCO Finland
Cholecystectomy
5.0
6.1
18
37
WX882
NOMESCO Finland
High dependency care
3.7
6.1
25
71
NB6AA
NOMESCO Finland
Humerus X-ray examination
6.2
6.0
15
25
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.7
6.0
16
29
Z31.5
ICD-10 Finland
Genetic counselling
3.2
6.0
30
99
A06AD11
ATC
lactulose; oral
2.1
6.0
73
385
I25.2
ICD-10 Finland
Old myocardial infarction
2.6
6.0
40
159
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
256
1068
3.66
47.93
9.1
3.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
177
635
3.66
40.76
8.9
3.1
mmol/l
0.8
0.8
1.81
172
591
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
383
2225
3.49
39.25
12.7
5.7
umol/l
10.8
12.0
0.89
374
2097
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
59
89
7.32
38.16
1.8
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
311
1650
3.09
36.21
13.5
8.1
inr
1.3
1.2
0.30
124
484
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
133
424
3.84
36.09
5.3
3.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
135
436
3.80
35.94
2.5
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
150
520
3.61
35.90
3.0
1.6
—
—
—
0
0
(4035726)
119
354
4.03
35.61
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
105
6.42
34.77
8.7
2.9
u/ml
0.3
0.3
0.19
38
55
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
359
2096
3.13
34.64
15.4
6.0
mmol/l
1.2
1.2
1.79
270
1782
(3013650) Neutrophils [#/volume] in Blood by Automated count
395
2476
3.23
32.81
21.9
8.4
e9/l
4.1
4.0
0.29
370
2164
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
49
72
7.39
32.35
7.1
7.2
iu/ml
384.2
205.6
—
10
13
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
128
428
3.61
32.06
7.1
4.2
u/l
242.7
257.8
0.32
119
405
(3024561) Albumin [Mass/volume] in Serum or Plasma
311
1770
2.79
29.79
10.9
4.3
g/l
33.4
35.8
8.65
298
1659
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
205
942
2.90
29.69
3.4
1.7
mg/l
1.4
1.1
0.77
168
718
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
330
1943
2.80
29.46
14.4
5.3
mmol/l
1.2
1.2
1.83
315
1755
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
94
274
3.94
28.60
2.3
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
267
1435
2.71
28.20
10.2
5.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
385
2487
2.92
28.17
10.3
4.2
mmol/l
6.7
6.7
0.21
373
2302
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
160
663
3.01
27.73
2.4
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
96
304
3.63
25.76
4.2
4.2
%
0.6
0.3
1.31
40
72
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
99
5.59
25.55
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
282
1611
2.57
25.53
5.5
3.5
ng/l
35.4
40.1
0.27
217
1102
(3011412) CD3 cells [#/volume] in Blood
30
32
9.87
25.52
3.7
2.5
e9/l
1.2
1.1
0.17
23
15
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
68
169
4.46
25.51
2.7
2.0
g/l
1.7
1.5
0.57
61
150
(3017181) Myelocytes/100 leukocytes in Blood
102
340
3.47
25.28
4.4
4.3
%
1.3
0.8
0.66
50
106
(3018418) pH of Serum or Plasma
238
1270
2.57
24.68
8.4
3.5
ph
7.4
7.4
0.25
90
231
(3003458) Phosphate [Moles/volume] in Serum or Plasma
132
523
3.02
24.47
16.2
4.8
mmol/l
1.1
1.1
0.28
127
477
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
48
7.73
24.44
1.6
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
100
336
3.43
24.43
4.2
2.6
e9/l
60.9
69.9
1.96
73
264
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
20
12.51
23.99
4.2
2.8
%
9.0
15.5
0.93
12
13
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
64
163
4.32
23.22
2.9
1.9
ug/l
1.8
1.9
0.03
59
144
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
78
5.90
23.10
1.7
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
335
2147
2.48
22.68
11.4
5.5
e9/l
0.0
0.0
0.25
308
1858
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
240
1330
2.45
22.42
4.2
2.2
u/l
51.3
56.7
1.84
231
1226
(3012501) Base excess in Blood by calculation
46
92
5.37
22.27
4.1
2.5
mmol/l
3.2
2.6
0.57
35
55
(3027945) Reticulocytes/100 erythrocytes in Blood
120
474
2.97
22.19
4.6
2.5
%
1.8
1.7
0.09
106
431
(3019069) Monocytes/100 leukocytes in Blood
320
2022
2.43
22.16
12.2
5.8
%
8.7
8.5
0.56
310
1901
(3001604) Monocytes [#/volume] in Blood
332
2138
2.44
21.95
11.3
5.4
e9/l
0.6
0.6
1.61
304
1841
(3010421) pH of Blood
50
109
4.95
21.95
3.9
2.5
ph
7.4
7.4
1.53
45
90
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
21
11.40
21.68
5.0
2.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
339
2211
2.44
21.67
12.0
5.7
e9/l
0.2
0.2
2.81
311
1951
(3002030) Lymphocytes/100 leukocytes in Blood
324
2074
2.41
21.57
11.8
5.6
%
26.6
28.8
2.53
314
1938
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
101
367
3.16
21.56
3.2
2.2
g/l
0.2
0.2
0.50
93
344
(3021440) Promyelocytes/100 leukocytes in Blood
93
322
3.28
21.51
4.2
4.4
%
0.3
0.1
0.88
47
93
(3019198) Lymphocytes [#/volume] in Blood
337
2201
2.42
21.34
11.4
5.5
e9/l
1.9
2.0
0.42
309
1947
(3006504) Eosinophils/100 leukocytes in Blood
316
2013
2.38
21.09
11.9
5.5
%
2.6
2.9
2.21
304
1878
(3018010) Neutrophils/100 leukocytes in Blood
320
2056
2.37
20.85
11.2
5.4
%
57.4
56.3
0.76
308
1931
(3022096) Basophils/100 leukocytes in Blood
308
1947
2.36
20.84
11.7
5.6
%
0.6
0.7
1.06
297
1820
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
48
106
4.87
20.74
1.9
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
115
470
2.84
19.81
2.4
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
86
302
3.20
19.35
4.3
4.5
%
0.4
0.1
0.45
41
81
(3004789) Transferrin [Mass/volume] in Serum or Plasma
131
582
2.65
19.13
4.2
2.2
g/l
2.3
2.3
0.85
125
536
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
125
545
2.68
18.94
4.4
2.2
%
23.4
23.0
0.11
114
467
(3015377) Calcium [Moles/volume] in Serum or Plasma
242
1429
2.26
18.63
6.6
3.1
mmol/l
2.3
2.4
2.61
219
1246
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
112
467
2.77
18.48
2.2
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
298
1920
2.23
18.45
7.2
3.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
32
8.14
18.42
1.4
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
192
1035
2.33
18.32
3.1
2.0
mg/l
3.1
3.0
0.16
164
882
(3022948) Iron [Moles/volume] in Serum or Plasma
136
632
2.54
18.01
4.3
2.2
umol/l
12.1
13.6
1.75
130
580
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
70
5.44
17.93
1.8
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
255
1559
2.21
17.80
4.3
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
54
6.03
17.30
1.8
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
216
1252
2.21
17.05
2.8
2.1
u/l
167.1
293.9
0.86
209
1177
(3014111) Lactate [Moles/volume] in Serum or Plasma
90
348
2.90
17.03
9.7
6.0
mmol/l
1.3
1.4
0.14
84
331
(3031040) Bacteria [#/volume] in Urine by Automated count
388
2834
2.32
17.02
6.7
4.2
e6/l
5.0
3362.9
—
5
54
(3044640) Blood type and Crossmatch panel - Blood
216
1257
2.20
16.83
5.3
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
33
63
5.51
16.76
2.1
1.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
95
4.59
16.69
3.1
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
223
1327
2.16
16.31
4.0
3.0
e6/l
209.6
123.3
0.31
192
1032
(3003396) Base excess in Arterial blood by calculation
103
438
2.67
16.22
10.1
6.3
mmol/l
1.4
1.2
0.15
91
346
(3026782) Osmolality of Urine
160
838
2.29
16.00
3.4
2.5
mosm/kgh2o
538.4
553.8
0.41
148
706
(3026008) Bacteria identified in Urine by Culture
215
1275
2.14
15.74
4.2
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
86
338
2.84
15.73
14.7
7.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
173
942
2.23
15.71
7.5
4.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
166
895
2.24
15.39
3.5
2.3
e6/l
5.8
5.8
0.00
148
784
(3030467) Casts [#/volume] in Urine by Automated count
202
1190
2.12
14.87
3.9
2.9
e6/l
0.3
0.4
0.87
164
897
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
98
425
2.60
14.76
5.6
4.0
ug/l
6.2
20.3
0.78
87
355
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
63
5.16
14.69
1.8
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
428
3348
2.35
14.60
17.6
6.8
u/l
85.3
79.6
1.39
418
3123
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
57
5.32
14.26
1.8
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
196
1163
2.08
13.98
3.8
2.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
202
1220
2.05
13.67
3.6
3.0
ng/l
1786.3
1070.5
1.05
179
1027
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
48
5.64
13.66
2.0
1.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
35
84
4.39
13.62
2.5
2.4
%
16.4
16.0
0.16
15
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
70
268
2.85
13.38
7.4
4.7
mmol/l
1.7
1.9
0.15
58
206
(3045142) Bone marrow Pathology biopsy report
25
46
5.65
13.18
1.8
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
67
256
2.85
12.84
2.0
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
238
1549
1.96
12.83
4.8
3.5
e6/l
58.3
105.8
0.94
196
1102
(3033658) Prothrombin time (PT) actual/Normal
175
1029
2.04
12.56
8.5
3.5
%
86.9
91.5
1.32
167
1007
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
81
4.27
12.48
2.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
38
104
3.86
12.43
5.4
2.6
mmol/l
25.4
25.2
0.08
32
88
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
222
1423
1.95
12.41
4.9
3.2
u/l
41.2
32.5
0.54
211
1354
(40761536) Microorganisms panel - Urine sediment
84
367
2.53
12.36
5.2
3.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
14
10.24
12.28
2.7
6.4
%
102.8
94.5
0.31
14
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
100
475
2.36
12.25
2.2
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
70
281
2.71
12.21
7.5
4.6
ph
7.4
7.4
2.39
13
27
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
261
1773
1.92
12.20
3.4
2.3
nmol/l
76.4
76.8
0.09
242
1573
(1616796) Gas panel - Central venous blood
34
87
4.10
12.18
4.0
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
191
3.03
11.87
11.7
7.8
—
—
—
0
0
(44790047)
24
47
5.30
11.84
1.7
1.6
—
—
—
0
0
(44790049)
24
47
5.30
11.84
1.7
1.6
—
—
—
0
0
(44790048)
24
47
5.30
11.84
1.7
1.6
—
—
—
0
0
(44806118)
24
47
5.30
11.84
1.7
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
15
5
30.78
11.70
3.1
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
114
3.61
11.61
1.5
1.3
ug/g
232.7
306.1
1.16
23
66
(40758558) Short blood count panel - Blood
179
1089
1.96
11.49
15.8
6.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
85
386
2.43
11.48
10.9
3.6
mmol/l
1.9
2.1
0.36
72
300
(3021589) Normoblasts [#/volume] in Blood
282
1991
1.87
11.46
25.5
8.4
e9/l
0.0
0.0
0.16
250
1629
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
132
3.37
11.20
2.7
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
93
3.83
11.13
1.4
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
75
4.18
11.09
4.8
3.6
%
56.2
58.2
0.27
30
75
(3019060) Gas panel - Arterial blood
63
253
2.69
10.96
7.1
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
102
512
2.22
10.90
19.4
20.2
inr
1.6
1.2
0.87
16
73
(3004809) Band form neutrophils/100 leukocytes in Blood
27
63
4.46
10.88
2.7
3.7
%
1.3
1.1
0.12
22
53
(3042631) Mycobacterium sp identified in Specimen
25
55
4.72
10.82
2.0
3.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
5
28.68
10.77
3.3
1.8
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
308
2.50
10.55
5.8
3.0
ng/l
246.6
196.0
0.44
66
279
(3030905) Polymorphonuclear cells [#/volume] in Blood
29
74
4.08
10.43
4.2
3.1
e9/l
3.9
4.4
0.45
29
74
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
113
601
2.11
10.40
2.1
1.6
—
—
—
0
0
(4281824)
22
45
5.05
10.34
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
337
2.42
10.33
2.8
2.3
ug/l
4.9
6.8
0.74
65
296
(3037467) Urinalysis macro (dipstick) panel - Urine
377
2979
1.88
10.12
6.9
4.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
70
312
2.43
9.80
8.0
3.5
ng/l
108.2
72.1
1.94
64
275
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
158
969
1.89
9.63
5.1
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
259
1850
1.77
9.53
4.9
2.6
ug/l
219.4
118.4
4.23
235
1699
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
33
5.61
9.51
2.2
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
179
1152
1.83
9.32
5.7
3.8
estimate
0.0
0.0
0.50
90
400
(3021601) Nitrite [Presence] in Urine by Test strip
289
2140
1.76
9.30
6.6
4.7
estimate
0.0
0.0
0.00
92
405
(3000093) Morphology [Interpretation] in Blood Narrative
16
27
6.08
9.17
1.7
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
67
303
2.38
9.08
1.5
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
134
795
1.91
8.96
5.9
3.5
ng/l
1856.4
387.5
0.51
105
606
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
35
113
3.24
8.96
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
290
2166
1.73
8.90
5.2
3.5
estimate
0.0
0.0
0.50
86
392
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
39
5.01
8.90
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
49
193
2.69
8.84
11.1
8.4
mmol/l
24.7
24.5
0.19
43
178
(3025941) Bacteria identified in Stool by Culture
52
212
2.61
8.77
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
99
3.37
8.76
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
52
4.37
8.73
1.8
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
128
761
1.89
8.46
2.2
1.7
nmol/l
1362.5
1191.1
1.10
102
577
(3035350) Ketones [Presence] in Urine by Test strip
284
2128
1.71
8.46
5.2
3.5
estimate
0.0
0.0
0.00
89
407
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
41
4.77
8.41
2.7
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
72
3.74
8.38
2.3
2.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
23
6.22
8.22
2.3
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
90
479
2.06
8.16
6.4
2.8
umol/l
6.9
7.7
0.36
84
423
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
127
762
1.87
8.13
7.1
2.7
mmol/l
2.5
2.4
0.98
114
675
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
50
208
2.55
8.09
11.5
3.9
mmol/l
23.8
24.2
0.48
44
188
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
143
892
1.82
8.08
1.8
1.7
pmol/l
435.5
438.4
0.05
119
744
(46235355) HIV 1 and 2 tests - Meaningful Use set
125
748
1.87
8.06
2.3
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
27
5.69
8.06
2.2
1.9
—
—
—
0
0
(3013512) EKG study
186
1259
1.73
7.91
4.9
3.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
24
5.96
7.89
2.3
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
91
3.31
7.78
2.3
2.1
g/l
124.8
130.2
0.45
19
66
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
8
15.30
7.74
1.2
2.4
%
201.1
130.0
—
12
8
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
36
4.84
7.69
1.4
2.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
18
6.80
7.63
3.1
2.7
u/ml
2429.3
840.7
0.56
12
18
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
12
8.47
7.60
1.7
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
155
1009
1.75
7.51
1.8
1.5
nmol/l
20.8
20.7
0.02
139
845
(3041096) Erythrocytes [Presence] in Urine by Automated
177
1197
1.71
7.48
4.9
3.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
46
4.24
7.33
1.8
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
229
1666
1.65
7.29
5.6
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
95
3.17
7.27
1.8
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
32
112
2.97
7.18
8.3
5.6
mmol/l
2.0
1.3
0.78
27
95
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
81
3.32
7.06
1.9
1.3
—
—
—
0
0
(3020891) Body temperature
39
155
2.63
6.93
12.6
4.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
53
3.88
6.86
2.1
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
36
4.55
6.75
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
37
4.43
6.53
1.6
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
130
2.72
6.52
1.4
1.4
iu/ml
0.3
0.1
0.31
12
24
(3013707) Erythrocyte sedimentation rate by Westergren method
386
3248
1.66
6.50
6.0
4.0
mm/h
16.5
12.1
4.72
358
2984
(3023419) Bacteria identified in Sputum by Culture
20
56
3.67
6.37
3.1
3.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
47
3.93
6.31
2.4
4.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
34
4.51
6.27
1.5
1.3
g/l
2.7
2.8
—
9
23
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
34
4.51
6.27
1.5
1.3
g/l
0.3
0.4
—
9
23
(3027135) IgG subclass 1 [Mass/volume] in Serum
15
34
4.51
6.27
1.5
1.3
g/l
8.8
7.0
—
8
24
(3037121) Protein [Mass/volume] in Urine
38
157
2.53
6.26
5.3
3.9
g/l
0.2
0.2
0.03
25
59
(3026493) Urate [Moles/volume] in Serum or Plasma
161
1105
1.65
6.25
4.1
2.6
umol/l
2523.3
8994.8
1.63
149
947
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
78
3.17
6.11
2.0
1.3
u/ml
248.9
281.4
0.22
17
44
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
135
2.62
6.07
1.8
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
31
4.61
6.01
3.6
2.2
e6/l
590.6
559.3
—
7
12
(3017569) Oxygen content in Arterial blood
10
16
6.35
5.97
2.0
2.4
—
—
—
0
0
(4062490)
15
36
4.26
5.85
1.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
241
2.18
5.84
2.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
55
276
2.11
5.81
2.2
2.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
70
387
1.93
5.66
2.5
2.3
u/l
38.6
34.4
0.18
55
333
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
17
5.97
5.64
4.5
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
17
5.97
5.64
4.7
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
37
161
2.39
5.48
2.6
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
345
2883
1.55
5.44
5.6
2.9
u/l
67.8
44.8
3.06
323
2676
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
5
16.22
5.42
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
34
4.20
5.39
6.4
2.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
47
229
2.15
5.36
9.1
2.7
u/ml
71.8
49.3
0.33
47
219
(3035637) Corticotropin [Mass/volume] in Plasma
18
53
3.48
5.35
2.4
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
18
5.64
5.34
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
224
1719
1.52
5.19
2.4
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
23
81
2.92
5.15
2.1
1.4
e6/l
19853.8
10775.0
0.83
18
65
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
6
13.51
5.09
2.4
5.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
60
3.25
5.09
1.5
1.4
g/l
1.4
0.8
0.28
12
49
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
50
3.48
5.06
2.8
1.7
pg
33.8
32.3
0.81
17
50
(40768797) Stomach Pathology biopsy report
93
581
1.73
5.05
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
148
2.38
5.05
2.7
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
128
870
1.62
5.05
2.1
1.4
g/l
2.1
2.4
0.97
101
518
(3022313) Gas panel - Capillary blood
44
214
2.15
5.04
8.3
4.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
78
2.90
4.87
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
37
3.86
4.84
1.3
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
14
37
3.86
4.84
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
42
3.65
4.80
1.1
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
7
11.58
4.79
1.0
1.0
%
99.3
115.0
—
8
7
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
20
5.08
4.79
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
108
2.58
4.78
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
479
4383
1.83
4.75
40.9
12.4
mg/l
27.6
22.6
2.26
439
3413
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
74
2.91
4.71
2.5
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
48
3.40
4.64
1.6
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
217
1697
1.47
4.40
2.5
1.9
pmol/l
90.2
95.7
1.00
127
875
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
66
2.95
4.37
1.2
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
105
703
1.61
4.36
3.2
2.8
e6/l
5.0
2.3
0.92
64
399
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
120
2.41
4.32
2.4
2.3
u/l
556.7
1024.7
0.31
11
47
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
22
4.61
4.32
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
22
4.61
4.32
1.5
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
22
4.61
4.32
1.0
1.0
—
—
—
0
0
(4306422)
16
51
3.20
4.24
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
36
3.68
4.23
1.7
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
33
155
2.20
4.15
1.7
1.4
g/l
0.3
0.2
0.61
28
147
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
38
189
2.09
4.14
8.8
5.5
mmol/l
24.4
24.9
0.61
38
184
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
27
117
2.38
4.08
8.9
3.9
mg/l
1.6
1.5
0.36
22
107
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
111
2.41
4.06
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
14
6.52
3.99
2.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
38
3.48
3.92
1.6
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
54
3.02
3.88
1.6
1.1
u/ml
5.4
1.6
—
7
16
(3044941) Cell count panel - Synovial fluid
15
49
3.12
3.83
2.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
102
2.42
3.79
1.7
1.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
39
3.39
3.78
4.1
3.3
%
56.3
54.7
—
6
28
(3042733) HLA Ab [Presence] in Serum
7
8
8.85
3.78
4.7
3.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
55
2.97
3.76
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
116
2.30
3.70
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
83
547
1.61
3.66
1.4
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
87
581
1.59
3.64
1.4
1.3
titre
677.1
490.9
0.35
14
125
(3045424) Erythrocytes [Presence] in Urine
17
62
2.80
3.62
1.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
74
2.62
3.59
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
9
7.86
3.57
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
14
46
3.10
3.55
1.2
1.5
nmol/l
0.3
0.3
—
8
35
(3044889) 12 lead EKG panel
346
3019
1.41
3.51
5.4
3.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
21
87
2.47
3.51
6.3
2.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
72
463
1.64
3.51
1.6
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
6
10.09
3.50
1.2
1.0
%
95.2
110.0
—
6
6
(40768806) Pleura Pathology biopsy report
13
42
3.15
3.39
1.7
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
10
7.07
3.37
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
77
509
1.60
3.36
2.8
2.2
ug/g
122.3
126.4
0.07
66
397
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
14
5.78
3.35
1.5
2.1
ug/l
135.6
61.0
—
8
14
(3000494) Fungus identified in Specimen by Culture
78
519
1.59
3.31
1.7
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
103
732
1.50
3.26
3.0
2.6
e6/l
1.5
1.1
0.32
62
424
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
28
3.62
3.21
1.7
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
118
2.17
3.15
5.1
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
20
4.56
3.12
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
20
4.56
3.12
1.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
12
5.89
3.03
1.4
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
5
10.08
2.98
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
30
156
1.98
2.96
3.8
3.5
u/ml
374.0
388.7
0.02
25
134
(3003694) ABO and Rh group [Type] in Blood
154
1201
1.40
2.96
1.8
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
35
3.19
2.94
2.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
52
2.74
2.91
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
64
2.55
2.89
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
58
2.63
2.89
1.6
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
9
22
4.14
2.89
1.1
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
47
2.81
2.83
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
59
2.59
2.81
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
59
2.59
2.81
1.6
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
42
2.90
2.76
1.5
1.6
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
6
8.40
2.75
4.2
1.8
u/l
480.6
3085.0
—
5
6
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
66
2.47
2.73
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
60
2.54
2.72
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
60
2.54
2.72
1.6
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
42
251
1.73
2.71
3.0
2.6
e6/l
0.1
0.2
0.90
42
243
(3006576) Bicarbonate [Moles/volume] in Blood
6
10
6.05
2.70
9.0
5.3
mmol/l
26.3
25.1
—
6
10
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
10
6.05
2.70
3.8
2.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
32
3.17
2.66
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
87
2.23
2.60
1.7
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
87
2.23
2.60
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
20
4.04
2.57
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
44
2.77
2.56
1.3
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
7
7.20
2.55
1.0
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
11
5.50
2.55
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
11
5.50
2.55
1.2
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
16
69
2.36
2.50
1.3
1.1
—
12.3
—
0
6
(3034770) Mitochondria Ab [Titer] in Serum
23
116
2.03
2.49
1.2
1.3
—
880.0
—
0
5
(3008536) Aspergillus sp Ab [Presence] in Serum
7
16
4.42
2.48
5.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
12
5.04
2.40
3.3
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
17
4.16
2.36
2.7
4.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
402
3700
1.34
2.29
44.6
15.3
%
14.4
13.6
17.11
396
3628
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
41
2.72
2.29
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
13
4.65
2.27
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
13
4.65
2.27
2.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
13
4.65
2.27
8.8
3.5
umol/l
29.8
28.9
—
6
13
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
13
4.65
2.27
5.5
2.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
13
4.65
2.27
2.0
1.2
%
91.3
93.6
—
6
13
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
7
18
3.92
2.26
1.4
1.2
mmol/l
5.3
7.3
—
7
18
(40760888) Immunoglobulin light chains.free panel - Serum
19
93
2.08
2.24
3.2
4.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
60
2.37
2.23
1.6
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
9
5.59
2.22
12.0
6.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
9
5.59
2.22
1.8
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
9
5.59
2.22
12.0
6.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
370
3373
1.31
2.21
4.8
3.9
pmol/l
15.0
14.8
1.23
330
3045
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
124
979
1.35
2.15
4.7
3.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
19
3.72
2.15
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
14
4.32
2.15
2.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
190
1.73
2.15
2.3
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
37
2.73
2.11
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
43
2.59
2.11
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
43
2.59
2.11
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
25
139
1.84
2.08
1.9
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
10
5.03
2.07
1.2
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
10
5.03
2.07
1.4
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
10
5.03
2.07
1.2
1.1
—
—
—
0
0
(4015189)
5
10
5.03
2.07
1.0
3.5
—
—
—
0
0
(3019225) pH of Specimen
58
403
1.49
2.07
9.2
4.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
69
2.21
2.06
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
69
2.21
2.06
4.9
2.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
15
4.03
2.04
1.0
1.1
miu/ml
1764.3
1474.2
—
6
15
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
404
4301
0.76
2.02
5.1
4.4
mmol/l
1.4
1.5
3.84
368
3945
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
32
2.84
2.01
3.7
1.9
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
71
518
1.43
1.98
11.7
6.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
64
2.22
1.96
1.3
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
33
2.76
1.94
1.2
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
174
1.70
1.90
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
50
345
1.50
1.86
5.9
3.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.56
1.84
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
35
2.60
1.81
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
35
2.60
1.81
1.0
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
409
4331
0.77
1.80
5.2
4.4
mmol/l
4.4
4.7
3.72
378
3998
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
29
2.78
1.79
3.4
3.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
358
0.57
1.78
2.0
1.7
—
—
—
0
0
(4268621)
10
41
2.47
1.76
2.3
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
34
218
1.60
1.75
2.6
2.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
36
2.52
1.74
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
36
2.52
1.74
1.2
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
24
2.94
1.72
1.6
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
21
118
1.81
1.72
1.7
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
415
0.61
1.71
1.1
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
6
19
3.18
1.66
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
19
3.18
1.66
1.5
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
19
3.18
1.66
1.5
2.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
150
1.70
1.66
1.8
2.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
7
25
2.82
1.65
3.3
2.8
nmol/l
71.0
84.8
—
7
25
(3022621) pH of Urine by Test strip
44
304
1.49
1.65
3.8
2.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15
77
1.98
1.60
1.3
1.2
u/l
49.6
14.9
0.49
15
65
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
26
2.71
1.58
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
7
26
2.71
1.58
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
20
3.02
1.58
1.5
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
20
3.02
1.58
1.7
2.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
471
4506
1.36
1.58
41.8
14.3
mmol/l
139.1
139.8
7.20
465
4367
(3026389) Candida sp identified in Specimen by Organism specific culture
11
50
2.23
1.58
1.6
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
57
2.13
1.56
1.6
1.2
u/ml
1.5
4.2
—
6
25
(3013727) Leukocytes other/100 leukocytes in Blood
5
15
3.35
1.52
2.0
4.6
%
48.0
47.6
—
5
15
(3036071) Salmonella sp Ab [Titer] in Serum
5
15
3.35
1.52
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
393
4158
0.80
1.52
4.8
3.9
mmol/l
1.4
1.3
2.19
355
3791
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
156
1.63
1.46
1.4
2.4
g/l
4.2
3.9
0.93
19
114
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
156
1.63
1.46
1.4
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
420
4404
0.79
1.44
5.4
4.9
mmol/l
2.6
2.8
2.93
385
4035
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
89
713
1.30
1.40
1.2
1.3
u/ml
24.6
10.3
0.55
31
273
(3019150) Specific gravity of Urine by Refractometry
117
971
1.26
1.40
6.0
3.7
kg/l
1.0
1.0
0.27
20
148
(3023103) Potassium [Moles/volume] in Serum or Plasma
471
4523
1.33
1.39
42.2
14.4
mmol/l
4.0
4.0
1.50
463
4379
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
99
809
1.27
1.34
1.6
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
39
0.00
1.34
0.0
4.0
—
34.8
—
0
11
(3009508) Creatinine [Moles/volume] in Urine
155
1334
1.23
1.34
3.5
3.1
mmol/l
6.6
7.5
1.58
134
1106
(3014271) Vancomycin [Susceptibility]
5
18
2.79
1.28
2.8
2.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
18
2.79
1.28
1.4
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
331
1.39
1.25
6.2
2.5
ml/min/173m2
57.9
68.3
1.08
24
126
(3051611) Lipemic interference index of Serum or Plasma
8
36
2.24
1.24
6.3
2.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
27.0
14.6
nmol/l
1400.5
1532.4
—
6
25
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
22.2
10.8
nmol/l
741.5
805.4
—
6
25
(3051651) Icteric interference index of Serum or Plasma
6
25
2.42
1.24
7.2
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
45
2.02
1.24
1.1
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
124
1.64
1.22
1.4
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
19
2.65
1.22
2.0
3.6
u/l
230.6
203.7
—
5
19
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
12
64
1.89
1.19
1.1
1.1
u/ml
0.7
1.2
—
5
10
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
79
1.79
1.18
1.4
1.2
u/ml
0.9
3.4
—
5
33
(3049717) Cytology report of Urine Cyto stain
26
174
1.52
1.17
3.2
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
298
2755
1.18
1.15
3.4
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
115
975
1.23
1.14
1.4
1.2
u/ml
1.2
1.3
0.10
35
255
(3037756) Immunofixation for Serum or Plasma
16
96
1.69
1.11
1.4
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
91
756
1.25
1.09
1.3
1.3
iu/ml
16.1
35.4
3.48
27
238
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
32
2.20
1.08
2.7
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
33
2.14
1.06
2.7
3.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
18
114
1.60
1.04
1.6
2.5
g/l
0.0
0.0
0.00
18
105
(3035285) Chloride [Moles/volume] in Venous blood
11
60
1.85
1.03
2.2
2.6
mmol/l
105.0
105.8
0.31
11
60
(3041354) Potassium [Moles/volume] in Venous blood
11
60
1.85
1.03
2.2
2.6
mmol/l
4.0
4.0
0.04
11
60
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
60
1.85
1.03
2.2
2.6
—
—
—
0
0
(1002224) Polysomnography panel
10
177
0.56
1.03
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
482
4680
1.28
1.00
22.5
9.7
u/l
28.0
25.9
1.53
472
4505
(1761868) Lipid panel - Serum or Plasma
138
1564
0.84
0.98
3.0
2.9
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
18
116
1.57
0.97
1.6
2.5
g/l
0.0
0.0
0.00
18
106
(40761511) CBC panel - Blood by Automated count
474
4596
1.26
0.97
36.8
11.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
62
500
1.27
0.96
2.9
1.6
%
1.5
1.5
0.01
56
441
(42529406) Shigella sp [Presence] in Stool by Culture
20
134
1.51
0.93
1.4
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
52
1.74
0.92
3.9
3.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
42
1.92
0.89
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
56
1.80
0.88
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
136
1.49
0.87
1.3
1.4
miu/ml
166.6
267.1
—
5
60
(36660697) Celiac disease serology panel - Serum
43
336
1.30
0.86
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
214
0.64
0.84
1.4
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
145
1297
1.16
0.80
4.4
4.0
mg/mmol
13.0
8.1
0.67
99
800
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
48
1.68
0.79
1.1
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
34
1.77
0.76
1.3
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
75
1.61
0.75
1.8
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
422
0.77
0.74
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
137
1228
1.16
0.74
3.6
3.2
mg/l
55.6
277.4
1.32
89
760
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
253
0.70
0.73
1.4
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
18
125
1.46
0.73
1.6
2.5
g/l
0.0
0.0
0.50
18
115
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
25
2.01
0.73
1.6
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
117
1.47
0.72
2.5
2.5
ug/min
272.2
79.4
0.36
11
68
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
134
1.43
0.72
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
134
1.43
0.72
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
301
1.28
0.71
4.2
2.8
e9/l
4.1
4.0
0.08
25
244
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
26
1.93
0.71
1.8
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
5
26
1.93
0.71
1.2
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
26
1.93
0.71
1.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
102
1.48
0.68
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
129
1.41
0.64
1.9
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
16
112
1.44
0.64
1.9
1.8
nmol/l
47.2
38.8
0.41
16
107
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
418
4049
1.14
0.63
5.7
4.6
mu/l
1.9
2.2
0.49
382
3665
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
79
687
1.18
0.63
1.4
1.5
—
—
—
0
0
(3000492) Spirometry study
33
411
0.79
0.62
1.6
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
130
1176
1.14
0.62
1.7
1.6
mmol/l
1.5
1.4
1.03
113
988
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
425
4124
1.14
0.62
33.2
11.6
ml/min/173m2
79.9
81.2
0.46
382
3347
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
6.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
300
1.25
0.60
1.2
1.2
iu/ml
101.5
162.8
0.69
12
119
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
65
749
0.85
0.58
2.6
3.0
ug/l
0.8
0.8
0.03
43
487
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
54
1.49
0.57
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
152
1.33
0.53
1.8
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
21
161
1.32
0.52
1.8
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
162
1.31
0.50
1.7
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
6
41
1.47
0.50
1.2
1.3
mosm/kgh2o
282.2
278.5
—
6
30
(3027008) Opiates [Presence] in Urine
21
163
1.30
0.49
1.8
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
21
163
1.30
0.49
1.8
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
148
1.29
0.44
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
45
388
1.17
0.43
2.0
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
113
1.34
0.43
2.0
1.7
iu/l
9.4
6.7
—
6
40
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
32
1.57
0.42
1.2
1.5
g/l
0.8
1.0
—
5
32
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
88
1.37
0.40
1.5
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
409
3996
1.10
0.39
34.1
13.5
%
37.3
39.9
5.25
261
2912
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
8.8
—
0
10
(4024509)
5
37
1.35
0.37
2.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
81
1.37
0.36
2.0
1.9
pmol/l
169.4
217.1
0.61
11
76
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
108
1.30
0.35
2.3
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
477
0.89
0.26
2.7
2.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
419
4255
0.93
0.26
5.3
4.5
mmol/l
6.1
5.9
1.10
373
3872
(3028707) Methadone [Presence] in Urine by Screen method
9
73
1.24
0.25
2.2
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
114
1.23
0.25
2.6
4.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
82
0.73
0.24
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
227
1.15
0.24
3.5
3.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
85
0.70
0.24
1.7
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
432
0.90
0.24
2.6
2.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
38
1.32
0.23
1.2
1.2
—
94.4
—
0
5
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
30
267
1.13
0.22
1.4
1.3
—
42.9
—
0
14
(3003129) Base excess in Capillary blood by calculation
0
11
0.00
0.21
0.0
1.1
—
2.7
—
0
11
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
23.4
—
0
10
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
0.7
—
0
5
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
103
0.77
0.21
1.5
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
51
1.18
0.19
2.3
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
270
1.12
0.19
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
397
4024
0.95
0.19
7.0
5.7
mmol/mol
40.8
39.8
1.05
364
3727
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
69
1.16
0.16
1.5
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
78
1.16
0.15
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
99
1024
0.96
0.12
3.3
4.2
%
21.5
21.6
0.02
44
482
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
211
1.09
0.11
2.9
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
475
1.06
0.11
1.6
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
105
1.15
0.11
2.8
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
114
0.87
0.09
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
145
0.89
0.09
4.3
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
88
1.14
0.08
1.6
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
166
1.09
0.08
1.1
1.1
—
—
—
0
0
(4034850)
12
133
0.90
0.07
18.3
10.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
550
0.96
0.07
4.8
4.6
%
30.9
31.7
0.18
40
358
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
74
1.08
0.07
2.1
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
(4094501)
9
105
0.85
0.06
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
492
4904
1.04
0.06
55.2
18.6
e9/l
255.4
250.3
0.74
480
4778
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
139
1.08
0.05
1.3
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
492
4905
1.04
0.05
54.9
18.5
fl
91.3
90.9
0.90
487
4830
(4010399)
31
323
0.96
0.05
1.4
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
492
4906
1.03
0.04
54.8
18.5
pg
30.2
30.3
0.66
487
4831
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
229
1.05
0.04
1.3
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
492
4907
1.03
0.04
55.0
18.5
e12/l
4.2
4.5
21.47
479
4763
(3010813) Leukocytes [#/volume] in Blood
492
4908
1.03
0.03
55.2
18.6
e9/l
7.1
6.7
1.77
479
4763
(3000963) Hemoglobin [Mass/volume] in Blood
492
4908
1.03
0.03
55.4
18.7
g/l
126.2
135.6
30.67
487
4829
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
127
1283
0.99
0.03
4.5
4.9
ug/l
4.8
2.5
0.58
113
1143
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
231
1.04
0.03
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
128
1.02
0.00
2.1
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
168
1.01
0.00
1.3
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
109
1.01
0.00
4.4
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
259
1.00
0.00
3.0
2.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
55
0.91
0.00
1.0
1.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
69
1.01
0.00
1.4
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
79
0.88
0.00
1.3
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
1.9
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
7.5
—
0
7
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC – Complications following infusion, transfusion and therapeutic injection
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).